Intestinal Biotech Development
Lille
About Intestinal Biotech Development
Intestinal Biotech Development focuses on inflammatory bowel diseases, irritable bowel syndrome, preclinical and clinical trial services.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Last round: Non-Equity Assistance (Mar 2005)
- Website: ibd-biotech.com
- Phone: 33 320490597
Industries & Categories
Biotechnology, Clinical Trials, Health Care
Social Profiles
Canonical: https://fsome.com/organization/intestinal-biotech-development-2629767 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.